The personalized cancer vaccine market is gaining rapid momentum, driven by biotech advancements and rising demand for targeted immunotherapies. The new 2025 report analyzes key players like BioNTech, ...

JPMorgan analyst Jessica Fye lowered the firm’s price target on Moderna (MRNA) to $33 from $40 and keeps an Underweight rating on the shares, ...

Some pearl-shaped bubble foods have been with us for a long time — not fads at all. Perhaps the classic is caviar, and fish eggs in general. Different fish eggs have different types of “pop” and ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that ...

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their ...

Real-time stock price for BMO Callable Equity Inc Notes S2641 Link Moderna (JHN14879.CF), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Klinger joined the Cambridge, Massachusetts-based pharmaceutical company in 2021, when Moderna's stock was trading at around $130, and later that year it climbed as high as $449, as investors rewarded ...

The "mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The mRNA cancer therapeutics market was valued at USD 13.23 ...

CompanyOverview|NASDAQ:MRNA] The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market. This is very significant since most of the insider trades have been sales for ...

Local government crews in Washington began on Monday morning to remove the Black Lives Matter mural that was painted near the White House nearly five years ago. Errin Haines discusses.March 11, 2025 ...

From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...

Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine inventors BioNTech and Pfizer. BioNTech, represented by Taylor Wessing, and ...